跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 301 条关于
“Jason Lettmann”
全部
301
临床试验
10
药物
1
机构
6
资讯
284
去年
ALX Oncology Highlights Evorpacept Data in Metastatic Breast Cancer at SABCS 2024
9个月前
ALX Oncology's Evorpacept Combination Achieves 92% Complete Response Rate in Frontline Indolent Non-Hodgkin Lymphoma Trial
去年
ALX Oncology Appoints Barbara Klencke as Interim Chief Medical Officer to Advance Cancer Pipeline
去年
Evorpacept-Keytruda Combination Fails to Meet Primary Endpoints in Head and Neck Cancer Trials
去年
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
去年
Vera Therapeutics Appoints Jason S. Carter as Chief Legal Officer
去年
PARTIQoL Trial Assesses Proton Therapy vs. IMRT for Localized Prostate Cancer
去年
Strand Therapeutics Appoints Cancer Immunotherapy Pioneer Dr. Jason Luke as Chief Medical Officer
上个月
Olema Oncology Appoints Jason O'Byrne as CFO Ahead of Pivotal OPERA-01 Data
8个月前
Genelux Appoints Dr. Jason Litten as Chief Medical Officer to Advance Oncolytic Immunotherapy Olvi-Vec
第 1 页,共 29 页
上一页
下一页